Products
Platform
Research
Market
Learn
Partner
Support
IPO

A

Artemis Medicare Services Share Price

238.2
-11.80 (-4.72%)
ARTEMISMED • 20 Jan, 2026 | 03:29 PM
Buywith MTF at 1x leverage

1Y Annualised Return

-16.81%

3Y Annualised Return

52.81%

5Y Annualised Return

62.78%

The current prices are delayed, login or Open Demat Account for live prices.

Artemis Medicare Services Stock Performance

1W Return-7.01
1Y Return-23.65
Today's Low236.95
Prev. Close250.00
Mkt Cap (Cr.)3,957.66
1M Return-13.77
3Y Return226.30
52-Week High335
Open249.30
PE Ratio41.43
6M Return-3.21
Today's High249.45
52-Week Low207.71
Face Value1

Artemis Medicare Services Company background

Founded in: 2004
Managing director: Devlina Chakravarty
Artemis Medicare Services Limited was incorporated on May 18, 2004. It commenced the commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007. The Company is the holding Company of Artemis Cardiac Care Private Limited and a Subsidiary of Constructive Finance Private Limited. At present, the Company is engaged in managing and operating of multi specialty hospitals. Artemis Hospital (a unit of Artemis Medicare Services Limited) is spread across 9 acres, is a 395 bed stateoftheart multispeciality hospital located in Gurugram, India. Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group. Designed as one of the most advanced in India, the Company provides a depth of expertise in the spectrum of advanced medical surgical interventions, comprehensive mix of inpatient and outpatient services.The Company commenced commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007. Artemis Hospital was the first to introduce Masimo technology based on Clinical Surveillance System and equipped with North Indias first M6 Cyber knife having performed over 1000 procedures. The hospital has an impeccable track record and high success rates even in surgeries of high complexity such as transplants, cardiac care and oncology. In addition to the focus on clinical excellence, the Hospital ensures that medical professionals and other staff are periodically trained on the newest techniques and procedures in the medical field on a periodic and continuous basis. The Hospital has put modern technology in the hands of renowned doctors from India and abroad as well to set new standards in healthcare. The medical practices and procedures followed in the hospital are research oriented and benchmarked against the best in the world. Topnotch services, in a warm, open patient centric environment, clubbed with affordability, has made the Unit one of the most revered hospitals in the country.In 201920, the amalgamation of Artemis Health Sciences Limited, Athena Eduspark Limited and Artemis Global Life Sciences Limited with the Company through the Scheme of Amalgamation was made effective from 01 April, 2018. In terms of the said Scheme. the Company allotted on October 26, 2019 an aggregate of 1,32,37,700 Equity Shares of Rs 10/ each to shareholders of Artemis Global Life Sciences Limited pursuant to Composite Scheme of Amalgamation. The Company commenced operations of new Tower II in Gurugram in 2022. Resulting the expansion of the Hospital Building, the bed capacity of the Hospital increased from 394 beds to 541 beds in 2022. The Company opened two new units of Daffodils by Artemis, one each in Jaipur and South Delhi in addition to the one already operating in Gurugram in 2023. In addition to this, it introduced the , multispeciality hospital under the brand of Artemis Lite catering to secondary/ tertiary care market and opened the first centre in South Delhi in 2023. In 2024, the Company made operational the remaining beds in the second tower and focused on improving operational and financial metrics. It opened a new unit under the Artemis Lite brand in New Gurugram area in June, 2023. Further, the Company established the first of the two hospitals in Mauritius, a 80bed facility under the brand of Artemis Curepipe Hospital as part of the Operations and Management agreement.

Artemis Medicare Services Financial Highlights


For the full year FY2025–2026, revenue reached ₹969.9 crore and profit touched at ₹82.18 crore. As of Dec '25, Artemis Medicare Services’s market capitalisation stood at ₹3,957.66 crores. Shareholding as of Dec '25 shows promoters holding 58.4%, with FIIs at 12.5%, DIIs at 9%, and public at 20.1%.

Artemis Medicare Services Share Price Today


As of 20 Jan 2026, Artemis Medicare Services share price is ₹238.2. The stock opened at ₹249.3 and had closed at ₹250 the previous day. During today’s trading session, Artemis Medicare Services share price moved between ₹236.95 and ₹249.45, with an average price for the day of ₹243.20. Over the last 52 weeks, the stock has recorded a low of ₹207.71 and a high of ₹335.00. In terms of performance, Artemis Medicare Services share price has declined by 3.2% over the past six months and has declined by 16.81% over the last year.
Read More
Artemis Medicare Services SIP Return Calculator
5,000
Over the past
Total Investment of ₹0
Monthly SIP of 5,000 would have become 0 in 5 years with a gain of 0 (+0.00%)
View details of Market Depth

Artemis Medicare Services Fundamental

Market Cap (in crs)

3,957.66

Face Value

1

Turnover (in lacs)

479.13

Key Metrics

Qtr Change %
28.90% Fall from 52W High
-2.4
Dividend yield 1yr %
Below industry Median
0.2

Artemis Medicare Services Key Financials

View more
Loading chart...
Artemis Medicare Services Quarterly Revenue
Artemis Medicare Services Yearly Revenue
Artemis Medicare Services Quarterly Net Profit/Loss
Artemis Medicare Services Yearly Net Profit/Loss

Artemis Medicare Services Result Highlights

  • Artemis Medicare Services Ltd reported a 7.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 13.5%.

  • Its expenses for the quarter were up by 4.7% QoQ and 11.3% YoY.

  • The net profit increased 41.5% QoQ and increased 35.6% YoY.

  • The earnings per share (EPS) of Artemis Medicare Services Ltd stood at 1.89 during Q2 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Artemis Medicare Services Shareholding Pattern

Promoter
58.4%
Foreign Institutions
12.5%
Mutual Funds
1.7%
Domestic Institutions
9%
Public
20.1%

Artemis Medicare Services Technical Analysis

Moving Averages Analysis
238.2
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
Day EMA5
257.00
Day EMA10
261.00
Day EMA12
262.20
Day EMA20
265.50
Day EMA26
266.70
Day EMA50
265.90
Day EMA100
261.30
Day EMA200
258.10
Delivery & Volume
Loading chart...

Day

45.90%

Week

51.30%

Month

54.10%

Delivery & Volume

252.63
Pivot
Resistance
First Resistance
257.17
Second Resistance
264.33
Third Resistance
268.87
Support
First Support
245.47
Second support
240.93
Third Support
233.77
Relative Strength Index
33.61
Money Flow Index
30.53
MACD
-4.42
MACD Signal
-2.28
Average True Range
7.90
Average Directional Index
22.66
Rate of Change (21)
-10.06
Rate of Change (125)
0.32
Compare

Artemis Medicare Services Latest News

16 JAN 2026 | Friday
09 JAN 2026 | Friday
05 JAN 2026 | Monday

Please be aware that Artemis Medicare Services stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account